top of page
Scientist with Test Tubes_edited_edited.jpg

EFIL turns LIFE around

Revolutionizing Metabolic and Related Disease Treatments

Our Current Focus

Animal Obesity

Human Obesity

Prader-Willi Syndrome

Local Fat Disease

EFIL targets metabolic diseases with innovative ACAT inhibitor treatments where traditional therapies fall short.hort.

EFIL BioScience

 

Suite 602, 686 Cheonggyesan-ro, Sujeong-gu, Seongnam, Gyeonggi-do, Republic of Korea

1330 Avenue of The Americas, STE 23A, New York, NY 10019, United States

Email: media@efilbio.com

​

Copyright ⓒ 2021-2026 EFIL BioScience All rights Reserved.

  • Facebook
  • LinkedIn
bottom of page